Latest healthtech and biotech deals
The largest from last week:
๐ฌ๐ง๐ฉ๐ช One of Europeโs leading providers of digital-first home healthcare, Cera Care, has secured over โฌ310M. Operating in the UK and Germany, the startup is freeing up hospital beds and empowering elderly and vulnerable patients to access better and more affordable care from the comfort of their own homes.
๐บ๐ธ Cleerly, a digital healthcare company creating a new standard of care for heart disease, announced that it has closed a Series C financing round of $223M.
๐ฎ๐ณ Eye care chain ASG Eye Hospital raised $188M in a round led by new investors General Atlantic and Kedaara Capital. This is the largest private equity funding in India's eye care industry after the $132M raised by Dr Agarwalโs Health Care Ltd, earlier in May.
๐ฌ๐ง F2G, a Manchester, UK-based clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat life-threatening rare fungal infections with a high unmet medical need, received $70M in financing.
Other notable deals from around the globe:
๐บ๐ธ Vicinitas Therapeutics, a biotechnology company advancing a proprietary targeted protein stabilization platform to develop novel therapeutics in cancer and genetic disorders, launched with $65M in Series A financing.
๐จ๐ณ Da Mi & Xiao Mi, a provider of therapy and rehabilitation services in China for children aged between 3 and 12 years old with Autism Spectrum Disorder (ASD), raised $42M in a Series D fundraising round.
๐บ๐ธ Atia Vision, a Shifamed portfolio company committed to improving patient outcomes through the development of a modular presbyopia-correcting intraocular lens (IOL), raised a $42M Series E financing round.
๐บ๐ธ Novasenta, a startup biotechnology company focused on the discovery and validation of novel targets to develop cancer therapies, raised $40M in Series A financing.
Read up on all the latest health deals in Dealroom.co